Rapamycin and Aging: What the Human Trials Actually Found

Does rapamycin slow aging in humans? Here is what the actual human trials found, ranked by how strong the evidence really is, from mouse lifespan studies to the first longevity trials in people. Rapamycin is the most talked about longevity drug in the world. In mice, the evidence is genuinely strong. In humans, the picture is more complicated, and the first real trials tell a different story than the headlines. WHAT THIS VIDEO COVERS: How rapamycin extends life in mice and why that result is so consistent What mTOR actually does and why slowing it matters for aging What the first human longevity trials measured, and what they found How strong the evidence is at each level: animal, safety, human aging What is still unknown EVIDENCE LABELS USED IN THIS VIDEO: Strong: replicated across multiple studies Solid and growing: large observational data Moderate: consistent but modest effects Suggestive or early: preliminary or single studies CHAPTERS: [keep existing chapter list from the current description; if none exist, add them, first entry must be 0:00] SOURCES: [list the studies named in the video: author, journal, year. One line each. Keep 1:1 with what is said on screen.] This channel covers longevity drugs and compounds by walking through the evidence tier by tier, from animal data to human trials, with the strength of each claim labeled honestly. No dosing advice, no protocols, no supplement pitches. Just what the research actually shows. This video is educational content, not medical advice. Rapamycin is a prescription immunosuppressant. Talk to a physician about anything you are considering. #rapamycin #longevity #aging